InvestorsHub Logo
Followers 108
Posts 4135
Boards Moderated 0
Alias Born 04/21/2011

Re: trind1009 post# 76897

Saturday, 02/08/2014 11:56:17 AM

Saturday, February 08, 2014 11:56:17 AM

Post# of 194796
I predict it would have zero impact. At this point, revenue from the supplement side is simply a bonus, or icing on the cake, given the massive revenue projections which will be coming from CEN-Biotech. I've been in here since early 2011 and negative earnings have never had an impact. FITX has been in development and growth phase which always equals terrible financials and poor earnings, so it is generally expected in stocks trading on these exchanges. However, with that said, they are actually bringing in good revenue from the supplement side, compared to many other stocks trading on these exchanges which only trade on ideas, rumors, or a simplified products without any real revenue. The next financials should partly reflect the earnings from now selling on bodybuilding.com (biggest online store), Amazon, etc., as those distributors were not in place, nor reflected, in the previous financials. GNC has placed products orders for Cenergy, but as far as I know they are not yet available to buy. I'm guessing they will soon though, but it won't be reflected in earnings either. Basically, I expect revenues to increase in the next fins, but I still expect them to look terrible, which should be expected, given the costs/debt involved to have gotten them to this point. However, those fins will immediately and drastically improve as soon as CEN-Biotech begins harvesting. That's when fins will then become relevant, after growth and the development phase has slowed/ended, and profitability begins...

FITX